Bio-Path Holdings, Inc.
BPTH
$0.10
-$0.02-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -9.51% | 4.96% | 10.91% | 0.98% | -10.33% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.15% | -19.01% | -24.31% | -26.17% | -23.58% |
| Operating Income | -0.15% | 19.01% | 24.31% | 26.17% | 23.58% |
| Income Before Tax | -6.21% | 31.32% | 38.46% | 36.94% | 31.81% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.21% | 31.32% | 38.46% | 36.94% | 31.81% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.21% | 31.32% | 38.46% | 36.94% | 31.81% |
| EBIT | -0.15% | 19.01% | 24.31% | 26.17% | 23.58% |
| EBITDA | -0.36% | 18.77% | 24.25% | 26.08% | 23.57% |
| EPS Basic | 87.17% | 89.40% | 79.36% | 69.87% | 59.45% |
| Normalized Basic EPS | 87.17% | 89.40% | 79.36% | 69.87% | 59.45% |
| EPS Diluted | 87.17% | 89.40% | 79.36% | 69.89% | 59.47% |
| Normalized Diluted EPS | 87.17% | 89.40% | 79.36% | 69.87% | 59.45% |
| Average Basic Shares Outstanding | 572.65% | 640.68% | 401.62% | 250.33% | 119.73% |
| Average Diluted Shares Outstanding | 572.65% | 640.68% | 401.62% | 250.33% | 119.73% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |